Sol-Gel Technologies Ltd. (SLGL)

↓ Download CSV

CIK 0001684693 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated L3
  • Fiscal year ends Dec 31

In fiscal 2025, Sol-Gel Technologies Ltd. reported revenue of $19.39M, up 68.0% from the prior year. The company ran a net loss, with a net margin of -31.6%. It held $29.92M in total assets against $7.11M in total liabilities.

Key ratios (FY2025)

-38.9%
Operating margin
-31.6%
Net margin
-26.9%
Return on equity
+68.0%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$19.39M$11.54M$1.55M$3.88M$31.27M$8.77M$22.90M$129.0K$174.0K
Operating Income-$7.54M-$12.01M-$29.30M-$16.24M$2.96M-$30.23M-$25.95M-$33.52M-$31.63M-$20.76M
Net Income-$6.13M-$10.58M-$27.24M-$14.92M$3.22M-$29.29M-$24.61M-$32.20M-$31.57M-$20.77M
EPS (Diluted)$-2.19$-3.79$-10.01$-0.65$0.14$-1.30$-1.26
Total Assets$29.92M$35.85M$45.29M$46.63M$69.19M$59.16M$61.30M$69.68M$15.31M$10.98M
Total Liabilities$7.11M$7.00M$6.64M$4.42M$13.60M$8.31M$8.84M$5.77M$68.01M$42.32M
Shareholders' Equity$22.81M$28.85M$38.64M$42.21M$55.59M$50.85M$52.47M$63.91M-$52.70M-$31.34M
Cash & Equivalents$11.03M$19.49M$7.51M$12.45M$20.09M$7.12M$9.41M$5.33M$5.02M$7.00M
Operating Cash Flow$322.0K-$13.89M-$17.73M-$9.48M-$7.69M-$25.24M-$22.50M-$23.47M-$24.09M-$18.50M
Capital Expenditures$47.0K$2.0K$134.0K$171.0K$143.0K$449.0K$597.0K$1.05M$1.93M$385.0K
Shares Outstanding2.79M2.79M27.86M23.13M23.13M23.00M20.40M18.95M6.29M6.29M